The first is a strategic research collaboration to establish a longitudinal biological, clinical, environmental view of skin health. It combines L’Oréal’s deep scientific knowledge of skin and Verily’s comprehensive clinical science capabilities, to decode and discover the links between exposome, skin aging, and deep biology of the skin.
The second is a partnership with Verily’s R&D Team and L’Oréal’s Active Cosmetics Division, to explore the development of new technologies and tele-diagnosis solutions such as sensors, and AI algorithms for dermatology and skincare, that can form the basis for new services.
“We are excited to partner with Verily, a world leader in precision health tech. L’Oréal’s century-long commitment to pioneering innovation has come from our strong belief in the intersection between science, formulations, and our unique Advanced Research capabilities to decode revolutionary scientific discoveries that will create the future of beauty” says Nicolas Hieronimus, Chief Executive Officer, L’Oréal Group. “Thanks to this partnership, we want to lead a new era of skin health, through tech and science, to enable every person around the world the most inclusive, personalized, powerful and precise programs for their skin at each stage of their lives.”
“Verily and L’Oréal believe in the transformative power of technology to enable precision beauty and health” says Stephen Gillett, President and COO, Verily. “We are pleased to partner with a world leader in cosmetic science to better understand and promote skin health.”
“We recognize skin health as a critical need for overall wellness as it not only impacts us physically in our daily lives, but also holistically. Our collective approach has the potential to identify the right intervention based on data, powered by Verily’s technology and clinical science abilities combined with L’Oréal’s beauty industry leading intelligence and dermatology network” says Brian Otis, Fellow, Co-Founder, Verily “The new partnership between L’Oréal and Verily promises innovation for dermatologists and consumers. We look forward to learning more about the skin as a result of their strategic research collaboration and we hope that the new algorithms and tools will improve consumer access to personalized information so people can care for their skin more effectively” says Dr. Amanda Oakley, President, International Society of Teledermatology.
Through two programs, the French beauty giant and Alphabet precision health company are hoping to better understand and characterize skin and hair aging mechanisms and to inform L’Oréal’s precision beauty tech strategy and product development.
The first initiative will be a strategic research collaboration to establish a longitudinal biological, clinical, environmental view of skin health and the second will be a partnership between Verily’s R&D team and L’Oréal’s Active Cosmetics division to explore the development of new technologies and tele-diagnosis solutions.
“We recognize skin health as a critical need for overall wellness as it not only impacts us physically in our daily lives, but also holistically. Our collective approach has the potential to identify the right intervention based on data, powered by Verily’s technology and clinical science abilities combined with L’Oréal’s beauty industry leading intelligence and dermatology network” says Brian Otis, Fellow, Co-Founder, Verily.
Nicolas Hieronimus, Chief Executive Officer, L’Oréal Group, reveals, “We are excited to partner with Verily, a world leader in precision health tech. L’Oréal’s century-long commitment to pioneering innovation has come from our strong belief in the intersection between science, formulations, and our unique Advanced Research capabilities to decode revolutionary scientific discoveries that will create the future of beauty. Thanks to this partnership, we want to lead a new era of skin health, through tech and science, to enable every person around the world the most inclusive, personalized, powerful and precise programs for their skin at each stage of their lives.”
L’Oréal Group and Alphabet ‘s health technology company Verily enter into a strategic partnership to improve skin health. A first in the field of beauty, the collaboration includes two programs that aim to better understand and characterize the mechanisms of skin and hair aging.
L’Oréal Group’s scientific skin knowledge and Verily’s extensive clinical science capabilities; Research will be conducted to establish a biological, clinical and environmental perspective on skin health. In the second program, L’Oréal Group’s Active Cosmetics division and Verily’s R&D team will work together to develop solutions that use sensors , artificial intelligence algorithms and tele-diagnosis to combat dermatological ailments .
L’Oréal Group CEO Nicolas Hieronimus said they are excited about their collaboration with Verily . Within the scope of cooperation; Through technology and science, we want to lead a new era of skin health that will provide our consumers around the world with inclusive, personalized, powerful and sensitive programs for their skin.” said.
Verily President and COO Stephen Gillett said, ” Verily and the L’Oréal Group believe in the transformative power of technology in beauty and health. We are delighted to collaborate with the L’Oréal Group on the path to better understanding and promoting skin health .”
Verily Co- Founder Brian Brian , who said that skin health is a need for general health, affects daily life not only physically but holistically. Otis , “Our collective approach; “It has the potential to identify the right intervention based on data.”
International Teledermatology Association, Dr. Amanda Oakley said, ” The new collaboration between the L’Oréal Group and Verily promises innovation for dermatologists and consumers. We look forward to learning more about skin. New algorithms and tools will enable consumer access to personalized information so that individuals can more effectively apply their skin to their skin ,” said Amanda Oakley. We hope he can take care of it.”